loading...
 This Article 
   
 Share 
   
 Bibliographic References 
   
 Add to: 
 
Digg
Furl
Spurl
Blink
Simpy
Google
Del.icio.us
Y!MyWeb
 
 Search 
   
2008 32nd Annual IEEE International Computer Software and Applications Conference
Contraindications, Precautions, Overdoses, and Adverse Reactions: What Software Engineering Can Learn from Pharmaceuticals
July 28-August 01
ISBN: 978-0-7695-3262-2
During the past 20 years, great methodological strides have been made by software engineering researchers. Prior to the 1980’s, most software engineering “research” was limited to “I invented something new, and I think others should use it.” Now, more and more, researchers are actually collecting empirical results via quantitative and qualitative research, with some even using the scientific method with controlled experiments. However, software engineering research has a long way to go. Mostly, such research has resulted in indications of positive effects caused by new or existing tools, methods, techniques, languages, models, etc. But little or no such research reports on the contraindications, precautions, effects of overdose, or adverse reactions of tools, methods, techniques, languages, models, and so on. This paper describes why gathering such results are essential for any discipline that desires to push technology into practice.
Index Terms:
software engineering, empiricism, research, pharmaceuticals, contraindication, adverse reaction, overdose
Citation:
Alan M. Davis, "Contraindications, Precautions, Overdoses, and Adverse Reactions: What Software Engineering Can Learn from Pharmaceuticals," compsac, pp.481-487, 2008 32nd Annual IEEE International Computer Software and Applications Conference, 2008
Usage of this product signifies your acceptance of the Terms of Use.